Search

Your search keyword '"Taback, Bret"' showing total 320 results
Start Over Author "Taback, Bret"
320 results on '"Taback, Bret"'

2. Fully Automated Postlumpectomy Breast Margin Assessment Utilizing Convolutional Neural Network Based Optical Coherence Tomography Image Classification Method.

Author

Mojahed, Diana, Ha, Richard, Chang, Peter, Gan, Yu, Yao, Xinwen, Angelini, Brigid, Hibshoosh, Hanina, Taback, Bret, and Hendon, Christine

Subjects
CNN, Lumpectomy, OCT, Algorithms, Breast, Breast Neoplasms, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Margins of Excision, Mastectomy, Segmental, Neural Networks, Computer, Postoperative Period, Tomography, Optical Coherence
Abstract

BACKGROUND: The purpose of this study was to develop a deep learning classification approach to distinguish cancerous from noncancerous regions within optical coherence tomography (OCT) images of breast tissue for potential use in an intraoperative setting for margin assessment. METHODS: A custom ultrahigh-resolution OCT (UHR-OCT) system with an axial resolution of 2.7 μm and a lateral resolution of 5.5 μm was used in this study. The algorithm used an A-scan-based classification scheme and the convolutional neural network (CNN) was implemented using an 11-layer architecture consisting of serial 3 × 3 convolution kernels. Four tissue types were classified, including adipose, stroma, ductal carcinoma in situ, and invasive ductal carcinoma. RESULTS: The binary classification of cancer versus noncancer with the proposed CNN achieved 94% accuracy, 96% sensitivity, and 92% specificity. The mean five-fold validation F1 score was highest for invasive ductal carcinoma (mean standard deviation, 0.89 ± 0.09) and adipose (0.79 ± 0.17), followed by stroma (0.74 ± 0.18), and ductal carcinoma in situ (0.65 ± 0.15). CONCLUSION: It is feasible to use CNN based algorithm to accurately distinguish cancerous regions in OCT images. This fully automated method can overcome limitations of manual interpretation including interobserver variability and speed of interpretation and may enable real-time intraoperative margin assessment.

Published
2020

3. Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Author

Boughey, Judy C, Alvarado, Michael D, Lancaster, Rachael B, Symmans, W Fraser, Mukhtar, Rita, Wong, Jasmine M, Ewing, Cheryl A, Potter, David A, Tuttle, Todd M, Hieken, Tina J, Carter, Jodi M, Jakub, James W, Kaplan, Henry G, Buchanan, Claire L, Jaskowiak, Nora T, Sattar, Husain A, Mueller, Jeffrey, Nanda, Rita, Isaacs, Claudine J, Pohlmann, Paula R, Lynce, Filipa, Tousimis, Eleni A, Zeck, Jay C, Lee, M Catherine, Lang, Julie E, Mhawech-Fauceglia, Paulette, Rao, Roshni, Taback, Bret, Goodellas, Constantine, Chen, Margaret, Kalinsky, Kevin M, Hibshoosh, Hanina, Killelea, Brigid, Sanft, Tara, Hirst, Gillian L, Asare, Smita, Matthews, Jeffrey B, Perlmutter, Jane, Esserman, Laura J, and I-SPY2 Investigators

Subjects
I-SPY2 Investigators
Abstract

[This corrects the article DOI: 10.1038/s41523-018-0074-6.].

Published
2019

5. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Author

Boughey, Judy C, Alvarado, Michael D, Lancaster, Rachael B, Fraser Symmans, W, Mukhtar, Rita, Wong, Jasmine M, Ewing, Cheryl A, Potter, David A, Tuttle, Todd M, Hieken, Tina J, Carter, Jodi M, Jakub, James W, Kaplan, Henry G, Buchanan, Claire L, Jaskowiak, Nora T, Sattar, Husain A, Mueller, Jeffrey, Nanda, Rita, Isaacs, Claudine J, Pohlmann, Paula R, Lynce, Filipa, Tousimis, Eleni A, Zeck, Jay C, Lee, M Catherine, Lang, Julie E, Mhawech-Fauceglia, Paulette, Rao, Roshni, Taback, Bret, Chen, Margaret, Kalinsky, Kevin M, Hibshoosh, Hanina, Killelea, Brigid, Sanft, Tara, Hirst, Gillian L, Asare, Smita, Matthews, Jeffrey B, Perlmutter, Jane, Esserman, Laura J, and and I-SPY 2 Investigators

Subjects
and I-SPY 2 Investigators, Clinical Trials and Supportive Activities, Clinical Research, Patient Safety, Cancer
Abstract

Advances in the surgical management of the axilla in patients treated with neoadjuvant chemotherapy, especially those with node positive disease at diagnosis, have led to changes in practice and more judicious use of axillary lymph node dissection that may minimize morbidity from surgery. However, there is still significant confusion about how to optimally manage the axilla, resulting in variation among practices. From the viewpoint of drug development, assessment of response to neoadjuvant chemotherapy remains paramount and appropriate assessment of residual disease-the primary endpoint of many drug therapy trials in the neoadjuvant setting-is critical. Therefore decreasing the variability, especially in a multicenter clinical trial setting, and establishing a minimum standard to ensure consistency in clinical trial data, without mandating axillary lymph node dissection, for all patients is necessary. The key elements which include proper staging and identification of nodal involvement at diagnosis, and appropriately targeted management of the axilla at the time of surgical resection are presented. The following protocols have been adopted as standard procedure by the I-SPY2 trial for management of axilla in patients with node positive disease, and present a framework for prospective clinical trials and practice.

Published
2018

7. Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanoma

Author

Moore, Michael R., Friesner, Isabel D., Rizk, Emanuelle M., Fullerton, Benjamin T., Mondal, Manas, Trager, Megan H., Mendelson, Karen, Chikeka, Ijeuru, Kurc, Tahsin, Gupta, Rajarsi, Rohr, Bethany R., Robinson, Eric J., Acs, Balazs, Chang, Rui, Kluger, Harriet, Taback, Bret, Geskin, Larisa J., Horst, Basil, Gardner, Kevin, Niedt, George, Celebi, Julide T., Gartrell-Corrado, Robyn D., Messina, Jane, Ferringer, Tammie, Rimm, David L., Saltz, Joel, Wang, Jing, Vanguri, Rami, and Saenger, Yvonne M.

Published
2021
Full Text
View/download PDF

14. Supplemental Table S1-4 and Supplemental Figure S1-S7 from Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Author

Gartrell, Robyn D., primary, Marks, Douglas K., primary, Hart, Thomas D., primary, Li, Gen, primary, Davari, Danielle R., primary, Wu, Alan, primary, Blake, Zoë, primary, Lu, Yan, primary, Askin, Kayleigh N., primary, Monod, Anthea, primary, Esancy, Camden L., primary, Stack, Edward C., primary, Jia, Dan Tong, primary, Armenta, Paul M., primary, Fu, Yichun, primary, Izaki, Daisuke, primary, Taback, Bret, primary, Rabadan, Raul, primary, Kaufman, Howard L., primary, Drake, Charles G., primary, Horst, Basil A., primary, and Saenger, Yvonne M., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table S1 from Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Author

Gartrell, Robyn D., primary, Marks, Douglas K., primary, Hart, Thomas D., primary, Li, Gen, primary, Davari, Danielle R., primary, Wu, Alan, primary, Blake, Zoë, primary, Lu, Yan, primary, Askin, Kayleigh N., primary, Monod, Anthea, primary, Esancy, Camden L., primary, Stack, Edward C., primary, Jia, Dan Tong, primary, Armenta, Paul M., primary, Fu, Yichun, primary, Izaki, Daisuke, primary, Taback, Bret, primary, Rabadan, Raul, primary, Kaufman, Howard L., primary, Drake, Charles G., primary, Horst, Basil A., primary, and Saenger, Yvonne M., primary

Published
2023
Full Text
View/download PDF

16. SupplementaryTable S4 from Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Author

Gartrell, Robyn D., primary, Marks, Douglas K., primary, Hart, Thomas D., primary, Li, Gen, primary, Davari, Danielle R., primary, Wu, Alan, primary, Blake, Zoë, primary, Lu, Yan, primary, Askin, Kayleigh N., primary, Monod, Anthea, primary, Esancy, Camden L., primary, Stack, Edward C., primary, Jia, Dan Tong, primary, Armenta, Paul M., primary, Fu, Yichun, primary, Izaki, Daisuke, primary, Taback, Bret, primary, Rabadan, Raul, primary, Kaufman, Howard L., primary, Drake, Charles G., primary, Horst, Basil A., primary, and Saenger, Yvonne M., primary

Published
2023
Full Text
View/download PDF

17. Data from Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Author

Gartrell, Robyn D., primary, Marks, Douglas K., primary, Hart, Thomas D., primary, Li, Gen, primary, Davari, Danielle R., primary, Wu, Alan, primary, Blake, Zoë, primary, Lu, Yan, primary, Askin, Kayleigh N., primary, Monod, Anthea, primary, Esancy, Camden L., primary, Stack, Edward C., primary, Jia, Dan Tong, primary, Armenta, Paul M., primary, Fu, Yichun, primary, Izaki, Daisuke, primary, Taback, Bret, primary, Rabadan, Raul, primary, Kaufman, Howard L., primary, Drake, Charles G., primary, Horst, Basil A., primary, and Saenger, Yvonne M., primary

Published
2023
Full Text
View/download PDF

18. Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM

Author

Clark, Joseph I., Wong, Michael K.K., Kaufman, Howard L., Daniels, Gregory A., Morse, Michael A., McDermott, David F., Agarwala, Sanjiv S., Lewis, Lionel D., Stewart, John H., Vaishampayan, Ulka, Curti, Brendan, Gonzalez, René, Lutzky, Jose, Rudraptna, Venkatesh, Cranmer, Lee D., Jeter, Joanne M., Hauke, Ralph J., Miletello, Gerald, Milhem, Mohammed M., Amin, Asim, Richart, John M., Fishman, Mayer, Hallmeyer, Sigrun, Patel, Sapna P., Van Veldhuizen, Peter, Agarwal, Neeraj, Taback, Bret, Treisman, Jonathan S., Ernstoff, Marc S., Perritt, Jessica C., Hua, Hong, Rao, Tharak B., Dutcher, Janice P., and Aung, Sandra

Published
2017
Full Text
View/download PDF

19. Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

Author

Boughey, Judy C., Alvarado, Michael D., Lancaster, Rachael B., Symmans, W. Fraser, Mukhtar, Rita, Wong, Jasmine M., Ewing, Cheryl A., Potter, David A., Tuttle, Todd M., Hieken, Tina J., Carter, Jodi M., Jakub, James W., Kaplan, Henry G., Buchanan, Claire L., Jaskowiak, Nora T., Sattar, Husain A., Mueller, Jeffrey, Nanda, Rita, Isaacs, Claudine J., Pohlmann, Paula R., Lynce, Filipa, Tousimis, Eleni A., Zeck, Jay C., Lee, M. Catherine, Lang, Julie E., Mhawech-Fauceglia, Paulette, Rao, Roshni, Taback, Bret, Goodellas, Constantine, Chen, Margaret, Kalinsky, Kevin M., Hibshoosh, Hanina, Killelea, Brigid, Sanft, Tara, Hirst, Gillian L., Asare, Smita, Matthews, Jeffrey B., Perlmutter, Jane, Esserman, Laura J., and I-SPY2 Investigators

Published
2019
Full Text
View/download PDF

20. Data from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

Author

Gartrell, Robyn D., primary, Marks, Douglas K., primary, Rizk, Emanuelle M., primary, Bogardus, Margaret, primary, Gérard, Camille L., primary, Barker, Luke W., primary, Fu, Yichun, primary, Esancy, Camden L., primary, Li, Gen, primary, Ji, Jiayi, primary, Rui, Shumin, primary, Ernstoff, Marc S., primary, Taback, Bret, primary, Pabla, Sarabjot, primary, Chang, Rui, primary, Lee, Sandra J., primary, Krolewski, John J., primary, Morrison, Carl, primary, Horst, Basil A., primary, and Saenger, Yvonne M., primary

Published
2023
Full Text
View/download PDF

21. Figure S1 from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

Author

Gartrell, Robyn D., primary, Marks, Douglas K., primary, Rizk, Emanuelle M., primary, Bogardus, Margaret, primary, Gérard, Camille L., primary, Barker, Luke W., primary, Fu, Yichun, primary, Esancy, Camden L., primary, Li, Gen, primary, Ji, Jiayi, primary, Rui, Shumin, primary, Ernstoff, Marc S., primary, Taback, Bret, primary, Pabla, Sarabjot, primary, Chang, Rui, primary, Lee, Sandra J., primary, Krolewski, John J., primary, Morrison, Carl, primary, Horst, Basil A., primary, and Saenger, Yvonne M., primary

Published
2023
Full Text
View/download PDF

22. Table S1 from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

Author

Gartrell, Robyn D., primary, Marks, Douglas K., primary, Rizk, Emanuelle M., primary, Bogardus, Margaret, primary, Gérard, Camille L., primary, Barker, Luke W., primary, Fu, Yichun, primary, Esancy, Camden L., primary, Li, Gen, primary, Ji, Jiayi, primary, Rui, Shumin, primary, Ernstoff, Marc S., primary, Taback, Bret, primary, Pabla, Sarabjot, primary, Chang, Rui, primary, Lee, Sandra J., primary, Krolewski, John J., primary, Morrison, Carl, primary, Horst, Basil A., primary, and Saenger, Yvonne M., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure Legends from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

Author

Gartrell, Robyn D., primary, Marks, Douglas K., primary, Rizk, Emanuelle M., primary, Bogardus, Margaret, primary, Gérard, Camille L., primary, Barker, Luke W., primary, Fu, Yichun, primary, Esancy, Camden L., primary, Li, Gen, primary, Ji, Jiayi, primary, Rui, Shumin, primary, Ernstoff, Marc S., primary, Taback, Bret, primary, Pabla, Sarabjot, primary, Chang, Rui, primary, Lee, Sandra J., primary, Krolewski, John J., primary, Morrison, Carl, primary, Horst, Basil A., primary, and Saenger, Yvonne M., primary

Published
2023
Full Text
View/download PDF

30. Efficacy of a password‐protected, pill‐dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery

Author

Cogan, Jacob C., primary, Accordino, Melissa K., additional, Beauchemin, Melissa P., additional, Spivack, John H., additional, Ulene, Sophie R., additional, Elkin, Elena B., additional, Melamed, Alexander, additional, Taback, Bret, additional, Wright, Jason D., additional, and Hershman, Dawn L., additional

Published
2022
Full Text
View/download PDF

31. Risk factors for breast cancer–related lymphedema in patients undergoing 3 years of prospective surveillance with intervention

Author

Koelmeyer, Louise A., primary, Gaitatzis, Katrina, additional, Dietrich, Mary S., additional, Shah, Chirag S., additional, Boyages, John, additional, McLaughlin, Sarah A., additional, Taback, Bret, additional, Stolldorf, Deonni P., additional, Elder, Elisabeth, additional, Hughes, T. Michael, additional, French, James R., additional, Ngui, Nicholas, additional, Hsu, Jeremy M., additional, Moore, Andrew, additional, and Ridner, Sheila H., additional

Published
2022
Full Text
View/download PDF

32. Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E

Author

Hallmeyer, Sigrun, Gonzalez, Rene, Lawson, David H., Cranmer, Lee D., Linette, Gerald P., Puzanov, Igor, Taback, Bret, Cowey, C. Lance, Ribas, Antoni, Daniels, Gregory A., Moore, Timothy, Gibney, Geoffrey T., Tawbi, Hussein, Whitman, Eric, Lee, Geraldine, Mun, Yong, Liu, Shiyao, and Hamid, Omid

Published
2017
Full Text
View/download PDF

38. Abstract P1-10-07: A randomized, controlled, 2x2 factorial trial of a diet and physical activity intervention among Latina breast cancer survivors: ¡Mi Vida Saludable! study

Author

Greenlee, Heather, primary, Santiago-Torres, Margarita, additional, Koch, Pamela, additional, Tsai, Wei-Yann, additional, Gray, Heewon L, additional, Brickman, Adam M, additional, Gaffney, Ann Ogden, additional, Eddy, Martha, additional, Thomson, Cynthia A, additional, Crane, Tracy E, additional, Dominguez, Naxielly, additional, Sepulveda, Jhack, additional, Marin-Chollom, Amanda M., additional, Paul, Rachel, additional, Shi, Zaixing, additional, Ulanday, Kathleene T, additional, Shen, Hanjie, additional, Castellano, Marisol, additional, Fuentes, Yanette, additional, Crew, Katherine, additional, Kalinsky, Kevin, additional, Accordino, Melissa, additional, Trivedi, Meghna, additional, Taback, Bret, additional, Beauchemin, Melissa, additional, Camacho, Fernando J, additional, Friedman, Daniel T, additional, Contento, Isobel, additional, and Hershman, Dawn L., additional

Published
2022
Full Text
View/download PDF

42. An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma

Author

Hasanov, Merve, primary, Milton, Denái R., additional, Sharfman, William H., additional, Taback, Bret, additional, Cranmer, Lee D., additional, Daniels, Gregory A, additional, Flaherty, Lawrence, additional, Hallmeyer, Sigrun, additional, Milhem, Mohammed, additional, Feun, Lynn, additional, Hauke, Ralph, additional, Doolittle, Gary, additional, Gregory, Nancy, additional, and Patel, Sapna, additional

Published
2021
Full Text
View/download PDF

43. Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial

Author

Boughey, Judy C., Suman, Vera J., Mittendorf, Elizabeth A., Ahrendt, Gretchen M., Wilke, Lee G., Taback, Bret, Leitch, Marilyn A., Kuerer, Henry M., Bowling, Monet, Flippo-Morton, Teresa S., Byrd, David R., Ollila, David W., Julian, Thomas B., McLaughlin, Sarah A., McCall, Linda, Symmans, Fraser W., Le-Petross, Huong T., Haffty, Bruce G., Buchholz, Thomas A., Nelson, Heidi, and Hunt, Kelly K.

Published
2013
Full Text
View/download PDF

49. Abstract B11: Prognostic biomarkers in stage II-III melanoma

Author

Rizk, Emanuelle M., primary, Gartrell, Robyn D., additional, Chen, Andrew, additional, Chang, Rui, additional, Marks, Douglas K., additional, Esancy, Camden L., additional, Taback, Bret, additional, Horst, Basil A., additional, Drake, Charles G., additional, Rabadan, Raul, additional, and Saenger, Yvonne M., additional

Published
2020
Full Text
View/download PDF

50. Presenting for Duty

Author

Rao, Roshni, primary, Sun, Luona, additional, Acevedo, Charise, additional, Concepcion, Ana, additional, Concepcion, Dionisia, additional, Sanchez, Josenny, additional, Alicea, Catherine, additional, Franco, Lisa, additional, Frias, Rosanna, additional, Flores, Adrianna, additional, Vega, Armisia, additional, Baez, Jennifer, additional, Soler, Nancy, additional, Alvarez, Sylvia, additional, Taback, Bret, additional, Rao, Madhu, additional, and Wiechmann, Lisa, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results